BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28011485)

  • 1. Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes But Not Normal Lymphocytes.
    Zhelev Z; Ivanova D; Bakalova R; Aoki I; Higashi T
    Anticancer Res; 2017 Jan; 37(1):149-159. PubMed ID: 28011485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docosahexaenoic Acid Sensitizes Leukemia Lymphocytes to Barasertib and Everolimus by ROS-dependent Mechanism Without Affecting the Level of ROS and Viability of Normal Lymphocytes.
    Zhelev Z; Ivanova D; Lazarova D; Aoki I; Bakalova R; Saga T
    Anticancer Res; 2016 Apr; 36(4):1673-82. PubMed ID: 27069145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the Pentose-phosphate Pathway Selectively Sensitizes Leukemia Lymphocytes to Chemotherapeutics by ROS-independent Mechanism.
    Zhelev Z; Ivanova D; Bakalova R; Aoki I; Higashi T
    Anticancer Res; 2016 Nov; 36(11):6011-6020. PubMed ID: 27793928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamins C and K3: A Powerful Redox System for Sensitizing Leukemia Lymphocytes to Everolimus and Barasertib.
    Ivanova D; Zhelev Z; Lazarova D; Getsov P; Bakalova R; Aoki I
    Anticancer Res; 2018 Mar; 38(3):1407-1414. PubMed ID: 29491065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Alpha-tocopheryl Succinate on the Cytotoxicity of Anticancer Drugs Towards Leukemia Lymphocytes.
    Ivanova D; Zhelev Z; Zlateva G; Lazarova D; Yaneva Z; Panovska R; Aoki I; Bakalova R
    Anticancer Res; 2022 Jan; 42(1):547-554. PubMed ID: 34969764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol Modulates the Redox-status and Cytotoxicity of Anticancer Drugs by Sensitizing Leukemic Lymphocytes and Protecting Normal Lymphocytes.
    Ivanova D; Zhelev Z; Semkova S; Aoki I; Bakalova R
    Anticancer Res; 2019 Jul; 39(7):3745-3755. PubMed ID: 31262901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Deoxy-D-glucose Sensitizes Cancer Cells to Barasertib and Everolimus by ROS-independent Mechanism(s).
    Zhelev Z; Ivanova D; Aoki I; Saga T; Bakalova R
    Anticancer Res; 2015 Dec; 35(12):6623-32. PubMed ID: 26637878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.
    Bakalova R; Semkova S; Ivanova D; Zhelev Z; Miller T; Takeshima T; Shibata S; Lazarova D; Aoki I; Higashi T
    Oxid Med Cell Longev; 2020; 2020():6212935. PubMed ID: 33204397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic"
    Bakalova R; Zhelev Z; Shibata S; Nikolova B; Aoki I; Higashi T
    Anticancer Res; 2017 Oct; 37(10):5449-5458. PubMed ID: 28982855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect.
    Büyükavci M; Ozdemir O; Buck S; Stout M; Ravindranath Y; Savaşan S
    Fundam Clin Pharmacol; 2006 Feb; 20(1):73-9. PubMed ID: 16448397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper-redox cycling by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated DNA damage and apoptosis: A mechanism for cancer chemoprevention.
    Khan S; Zafar A; Naseem I
    Chem Biol Interact; 2018 Jun; 290():64-76. PubMed ID: 29803612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
    Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis.
    Ganguly A; Basu S; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Chaudhuri SK
    Mol Biosyst; 2011 May; 7(5):1701-12. PubMed ID: 21409205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells.
    Uguz AC; Cig B; Espino J; Bejarano I; Naziroglu M; Rodríguez AB; Pariente JA
    J Pineal Res; 2012 Aug; 53(1):91-8. PubMed ID: 22288984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of rosmarinic acid from Salvia miltiorrhiza in acute lymphoblastic leukemia cells.
    Wu CF; Hong C; Klauck SM; Lin YL; Efferth T
    J Ethnopharmacol; 2015 Dec; 176():55-68. PubMed ID: 26476154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.
    Efferth T; Giaisi M; Merling A; Krammer PH; Li-Weber M
    PLoS One; 2007 Aug; 2(8):e693. PubMed ID: 17668070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of TRAIL cytotoxicity by AG-490 in human ALL cells is characterized by downregulation of cIAP-1 and cIAP-2 through inhibition of Jak2/Stat3.
    Lanuti P; Bertagnolo V; Pierdomenico L; Bascelli A; Santavenere E; Alinari L; Capitani S; Miscia S; Marchisio M
    Cell Res; 2009 Sep; 19(9):1079-89. PubMed ID: 19564891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cu(II)-coumestrol interaction leads to ROS-mediated DNA damage and cell death: a putative mechanism for anticancer activity.
    Zafar A; Singh S; Naseem I
    J Nutr Biochem; 2016 Jul; 33():15-27. PubMed ID: 27260464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic killing of human leukemia cells by antioxidants and trichostatin A.
    Kang J; Chen J; Zhang D; Da W; Ou Y
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):537-45. PubMed ID: 15248029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.